Nanobiotix is trading at $28.18, down 10.18%, in a pullback after a sharp rebound.
- No clear company-specific announcement was identified for November 2.
- A market report described the decline as a pullback amid recent volatility; the broader biotech sector is also under pressure.
- The October 24 melanoma-study update is earlier news and is not an established cause of today’s drop.